A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Virti XR Tech Providing Socially-Distanced Solutions for Medical Device Manufacturers

New technologies are enabling the medical device industry to embrace cutting-edge extended reality (XR) and immersive training to drive growth whilst complying with virus-control precautions.

Virti, a pioneering XR and immersive technology training company led by healthcare professionals, are bringing tools to transform device-specific training and sales demonstrations to the UK market. They have already embarked on partnerships with a number of leading UK manufacturers.

Virti’s digital platform hosts immersive video content accessible via smartphones, tablets or AR/VR headsets. The company also enables existing libraries of 2D content to be made interactive while tracking engagement and analyzing performance using artificial intelligence. Device manufacturers can create and upload their own content – complete with animations and voice instructions – for clients and potential customers to interact with remotely and then analyze how their content and products are being used.

This means that new technologies – from ventilators to surgical tools – can be virtually tested by prospective buyers and that medical professionals can participate in customized training activities that prepare them to use a particular device or medication safely.

Barriers of scale and distance can be eliminated through the application of Virti’s data-driven platform, as no travel or in-person instruction is required. Additionally, trials have proven that XR-taught professionals gain and retain competence at an accelerated rate, whilst also experiencing elevated confidence levels and decreased anxiety.

The training technology has already been successfully used to prepare NHS staff to serve on the frontline of the COVID-19 crisis response, and plans are underway to incorporate remote XR technology into other health sector education settings. These include the upskilling of mental health specialists in London and training of registrar anesthetists in the west of England.

Dr. Alex Young, Virti Founder, comments: “The medical device industry is undergoing a rapid transition in order to thrive in a changed marketplace. At Virti, we are honored to be playing a key role in this industry adaptation empowering sales and marketing teams and collecting unique data on how products are utilized”

“With 2-metre distancing now mandatory and long-distance travel extremely difficult, our technology makes it easy to deliver extremely effective sales demonstrations and impactful training while collecting analytics both pre- and -post product launch. Prospective customers can now ‘use’ new devices before purchase, and new purchasers can immediately be offered necessary training,”

“We are continuing to develop additional features and capabilities which will add value to our partnerships, and we believe that, when it comes to sales and training, we can help manufacturers to emerge from the current crisis better equipped to overcome barriers of distance and scale.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.
“We are excited to present the first look at the safety and clinical activity of ELVN-001, which we believe supports the potential for ELVN-001 to address the limitations of the available active-site TKIs,” said Helen Collins, M.D., Chief Medical Officer of Enliven. “Across a wide dose range, ELVN-001 demonstrated activity in a heavily pre-treated patient population that includes post-asciminib patients, with a preliminary safety profile consistent with its highly selective design. Not only did all evaluable patients have improved or stable BCR::ABL1 transcript levels, but, importantly, 89% of all patients enrolled remain on study. We believe the initial data demonstrate the potential clinical utility of ELVN-001 for all types of patients, including those that are earlier in the treatment paradigm.”
The partnership is with Health-HavenRx ™, an online pharmacy platform. This partnership enables a new, convenient channel for patients to access POGO Automatic by using their health insurance on Intuity Medical’s e-commerce website at www.GoodtoPogo.com.

By using this website you agree to accept Medical Device News Magazine Privacy Policy